| AH Controls #305 | AH Treated #212 | Difference | Benefit | ||||
---|---|---|---|---|---|---|---|---|
Published Study [Ref. #] | Number | mg/kg/wk | Mean SDS | Mean SDS | Mean SDS | Males cm | Females cm | |
Lopez-Siguero et al. [4] | 35 | 0.16 to 0.25 | -2.03 | -1.31 | 0.72 | 4.86 | NA | |
Coutant et al. [5] | 32 | 0.16 | -2.08 | -2.10 | -0.02 | -0.13 | -0.12 | |
Lopez-Siguero et al. [6] | 20 | 0.16 to 0.25 | -2.01 | -1.46 | 0.55 | 3.71 | NA | |
Leschek et al.* [1] | 22 | 0.22 | -2.34 | -1.77 | 0.57 | 3.84 | 3.50 | |
Hindmarsh et al. [7] | 16 | 0.16 to 0.28 | -1.88 | -1.33 | 0.55 | 3.71 | 3.38 | |
Buchlis et al. [8] | 36 | 0.3 | -2.10 | -1.50 | 0.60 | 0.4Â M 1.2Â F | 3.00 | 6.8 |
Albertsson-Wikland et al.* [3] | 31 | 0.47 | -2.20 | -1.50 | 0.70 | 5.0 | 4.30 | |
McCaughey et al.* [2] | 8 | 0.35 0.4 to 0.31 | -2.37 | -1.14 | 1.23 | NA | 7.55 | |
Wit et al. [9] | 12 | 0.32 0.32 to 0.26 | -2.40 | -1.30 | 1.10 | 7.42 | 6.75 | |
Total number | 212 | Â | Â | Â | Â | Â | Â | |
Mean | 23.6 | Â | -2.16 | -1.49 | 0.67 | 3.92 | 4.83 | |
Minimum | 8 | Â | -2.40 | -2.10 | -0.02 | -0.13 | -0.12 | |
Maximum | 36 | Â | -1.88 | -1.14 | 1.23 | 7.42 | 7.55 | |
Our study treated | 88 | 0.32 (0.03) | (-2.16) (Historical) | -0.71 | 1.45 | 9.8 | 8.9 | |
Difference | Â | Â | Â | Â | Â | Â | Â | |
Mean | Â | Â | Â | +0.78 | +0.78 | 5.2 | 4.8 | |
Minimum | Â | Â | Â | +0.43 | +0.22 | 1.5 | 1.35 | |
Maximum | Â | Â | Â | +1.39 | +1.47 | 9.9 | 9.0 |